The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.
about
Open versus robotic cystectomy: Comparison of outcomesMultimodal management of muscle-invasive bladder cancerEZH2 in Bladder Cancer, a Promising Therapeutic TargetLymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.In vitro culturing of viable circulating tumor cells of urinary bladder cancer.Current therapeutic strategies for invasive and metastatic bladder cancer.Extracapsular Extension of Pelvic Lymph Node Metastasis is an Independent Prognostic Factor in Bladder Cancer: A Systematic Review and Meta-analysis.Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.Pattern of lymph node metastasis correlates with tumor location in bladder cancer.External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder.Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder CancerPerioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer.Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncologyUpdate on the management of invasive bladder cancer 2012.A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis.Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era.Current management of muscle-invasive bladder cancer.Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.Perioperative chemotherapy for upper tract urothelial cancer.Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract.Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review.Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer: a prospective clinical study.Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.Landmarks in the treatment of muscle-invasive bladder cancer.Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer.Laparo-endoscopic single-site radical cystectomy with orthotopic urinary diversion: Technique, feasibility, and the 3-year follow-up.Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.Extent of pelvic lymph node dissection in penile cancer may impact survival.A standardized protocol for identifying and counting lymph nodes harvested by pelvic lymph node dissection at the time of radical cystectomy.Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer.Laparoscopic radical cystectomy: initial experience using the single-incision triangulated umbilical surgery (SITUS) technique.Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.Development and external validation of lymph node density cut-off points in prospective series of radical cystectomy and pelvic lymph node dissection.
P2860
Q26744160-89DDEB60-A64C-47C5-922A-1A735B4CD741Q27011624-FA1FE12A-6999-4813-AEBC-8086112304EEQ28082054-29DB43B1-B19A-4CB3-9D42-F76DA15B37DAQ33669763-E685F227-C9B9-48FD-BB72-3037F18685FFQ34501556-A45F5541-1F51-4758-B25D-FF6A30A48D30Q35128721-FB89B1B6-9926-4A69-A02D-706897FB5825Q35547533-ED1BE33F-6721-48CC-BAF2-26D1D50B9884Q35590489-538E45B5-D228-4523-9380-0DF2E9221B5EQ35592277-94472D38-A927-4C38-B7A0-38ACF875DF97Q35738210-308DA003-609F-4FD8-A0B4-A38D2E6CAAC1Q35794995-089F47E6-8EE8-484B-9AE1-B4F363526706Q35856850-55A4FF8F-81DC-4E40-A70B-361C973641FBQ35960332-AE6EF55F-9C6A-4C88-A9BD-637684C0E4C3Q36120392-1F425DA3-BBC9-415C-A952-3C4EAB4CFE5CQ36171243-6AEEDBAA-A44B-419A-A39A-9167759E4280Q37641597-24BC5E62-E9CE-4B43-8924-F51C1CBB926FQ37642789-816576AE-6945-4935-BA15-1C8F53B71A68Q37962658-88A836E6-4E7D-4145-9B31-F0054DA46A2CQ37992672-D70EECEB-91F8-4B8B-AE4F-C5F305676943Q38001253-60A88E04-F92A-40A3-9EE9-F45E4DAD90D0Q38003684-BC45AB82-059C-40B0-B8B3-F54458E91FBCQ38124003-11B998EF-4AF2-41D5-882E-34738192D5C5Q38768462-5E24938B-4D9E-4FF5-8F4D-A493F565D96FQ38941344-E08E63BE-8B86-42C5-9BEB-EA54630FCFE2Q39022354-EA4B11D6-BD04-4FD2-9C2C-FDCDDF5FB674Q39232727-4EB65D5D-B425-4DD4-A0E6-A69F7B2C581BQ39397592-484684AD-EC39-4DC2-8DD9-A27D3FE3A288Q39413207-8FEF7F3E-F0FC-4AB8-B284-29FBF9ABB624Q39772179-04CE8DFD-A664-492E-8EB7-AE567C8A351DQ40795695-B30E3BD4-E75E-4D90-8E6A-E163637AC7D3Q40833210-213FB3FB-54A4-442A-8235-1C4A747FF7BAQ41706002-BA0BDCC9-6BF6-4A11-B951-30935E567AEAQ41893474-46117D18-219C-4B2F-A9C0-907E850FB741Q42451041-5E7FA691-5B24-40AD-9BDE-AD8E1D63131DQ42660056-C4878BB8-F537-4E92-A30C-479716E6EBF8Q42665316-265E9792-4972-4AC7-A0A8-AC1D945717ACQ42677000-7763A8D5-618F-49BA-B121-6A32181C6BCFQ43582440-092C6939-40A7-4342-8D76-333F116CF092Q43742712-25068E8A-09B2-48D5-9812-BCF608A61456Q44042378-C1BE0C09-898D-4BA3-922A-A7553A8B108A
P2860
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@en
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@nl
type
label
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@en
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@nl
prefLabel
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@en
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@nl
P2093
P50
P1433
P1476
The impact of lymphadenectomy ...... cystectomy for bladder cancer.
@en
P2093
Alexander Karl
Jürgen E Gschwend
Peter R Carroll
Urs E Studer
P304
P356
10.1016/J.EURURO.2009.01.004
P407
P577
2009-01-13T00:00:00Z